Management of heparin-induced thrombocytopenia: systematic reviews and meta-analyses.
Morgan RL, Ashoorion V, Cuker A, Begum H, Ross S, Martinez N, Chong BH, Linkins LA, Warkentin TE, Wiercioch W, Nieuwlaat R, Schünemann H, Santesso N.
Morgan RL, et al.
Blood Adv. 2020 Oct 27;4(20):5184-5193. doi: 10.1182/bloodadvances.2020002963.
Blood Adv. 2020.
PMID: 33095876
Free PMC article.
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug reaction occurring in <0.1% to 7% of patients receiving heparin products depending on the patient population and type of heparin. ...
Heparin-induced thrombocytopenia (HIT) is a prothrombotic adverse drug reaction occurring in <0.1% to 7% of patients …